Australia Eases Capital Gains Tax Reforms to Support Small Businesses and Startups 
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want 
The American mass exodus to Canada amid Trump 2.0 has yet to materialize 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
OpenAI's $34B Spending Pushes AI Market Leadership Ahead of IPO 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
Dollar Slips as U.S.-Iran Peace Deal Optimism Boosts Risk Appetite Ahead of Fed Decision 
Debate over H-1B visas shines spotlight on US tech worker shortages 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
Asian Stocks Rally as Japan and South Korea Reach Record Highs on US-Iran Peace Deal 
GM Explores Defense Manufacturing Partnership With Lockheed Martin 
Asian Stocks Advance as Nikkei Nears Record High Ahead of Fed Decision 
Google promotes ‘teacher approved’ apps for kids. Here’s what parents should know 
Why a ‘rip-off’ degree might be worth the money after all – research study 
BioNTech SE, a Mainz-based German biotech firm, confronts a homegrown lawsuit seeking compensation for purported COVID-19 vaccine side effects. The initial case, scheduled for court on June 12, is expected to precipitate nationwide litigation.
BioNTech is set to attend the first court hearing on Monday, June 12. It will go to court to defend itself from the first case filed by a German woman who allegedly suffered from side effects after receiving her COVID-19 jab. She is seeking damages, and more cases are expected to be filed across the country after this.
According to Reuters, the plaintiff is suing the biotech firm and asking for at least €150,000 or about $161,500 in damages. The regional court in Hamburg said that in her lawsuit, the woman said the amount is for bodily harm and other material damages that were not specified.
For this case, she is being represented by Rogert & Ulbrich law firm. She claimed that after the jab, she suffered from pains in the upper part of her body, developed a sleeping disorder, fatigue, and swollen extremities. Her lawyer, Tobias Ulbrich, told the publication that will challenge the assessment made by European Union regulators and the vaccine assessment bodies in Germany that said the BioNTech vaccine has positive benefits.
In any case, it was mentioned that under German pharmaceutical law, drug or vaccine makers are only liable to give compensation for side effects if medical science shows that their products bear incorrect information or have caused disproportionate harm commensurate to their benefits.
With this, BioNTech believes that after a careful review and consideration of the case, it concluded that the lawsuit holds no merit. It also noted that the same vaccine was already received by some 1.5 billion people around the world, including more than 64 million Germans.
Meanwhile, despite BioNTech’s statements, Financial Times reported that the law firm representing the woman insisted that the burden of proof and the possible compensation is lower in Germany. Thus, it is confident that their case against BioNTech is strong.
Photo: Mat Napo/Unsplash
